The Settlement Layer for High-Value Care

Transition from the friction of prior-authorization to the certainty of Fee-for-Veracity. RegenMed provides the decentralized infrastructure to verify clinical outcomes at the source, ensuring that every dollar spent on high-cost interventions is justified by Deterministic Ground Truth.

Observational Protocols

Go Deeper

Moving Beyond the "Inference Gap"

The Problem: Current adjudication models rely on "Secondary Data Sets" — claims, billing codes, and administrative notes — to guess at the value of an intervention. Because this data requires significant "inference" to determine clinical success, it creates a permanent state of risk-uncertainty.

The Actuarial Bottlenecks:

The Sin of Omission

Payers inadvertently authorize low-value care because it fits within "pre-negotiated" static rulebooks that are easier to administer than innovative alternatives.

The Sin of Omission

FDA-approved breakthroughs are denied coverage simply because traditional "data exhaust" (claims) cannot capture the longitudinal nuance of a procedure's success, leading to legal and reputational risk.

Prior-Auth Attrition

The administrative "hoops" required to verify value create friction in the provider network and delay necessary care for the patient.

Verified at the Point of Care

The Solution: We replace "trust-based" arguments with engineering solutions. By Structuring at the Source, we provide the deterministic evidence that allows a Payer’s system to "learn" and adjudicate value in real-time.

The Adjudication Rails:

Deterministic Integrity

Outcomes are minted at the primary source, providing high-fidelity, longitudinal proof that overrides the ambiguity of legacy claims data.

Fee-for-Veracity Framework

A new reimbursement model where payment is tied to objective, verifiable results captured as a byproduct of the physician’s clinical workflow.

Structured Note Defense

Payers receive the specific data required for compliance and value validation without the need for provider data-reentry or manual audits.

Stabilizing VBC Risk

Eliminating Actuarial Drift

Scale Value-Based Care (VBC) contracts with confidence, knowing that outcomes are being tracked with 0% "inference risk".

Bridging the Coverage  Gap

Authorize FDA "breakthrough" treatments with the security of a longitudinal verification layer that tracks the real-world effectiveness of the device or drug post-launch.

Network Sustainability

Reduce provider burnout and administrative overhead within your network by replacing documentation "hoops" with a seamless, structured evidence engine.